Esketamine nasal spray compassionate use program in the Netherlands: An open label, multi-center cohort study in severe treatment-resistant depression
Abel Busz(GGZ Drenthe), Henricus G. Ruhé(Radboud University Nijmegen), Marasha de Jong, Etienne Olivier(University of Sharjah), Harry Venema(GGZ Drenthe), Jasper B. Zantvoord, Sara Schutters(Maastricht University), Koen Schruers(Maastricht University), Martijn van Noorden, Dieuwertje de Waardt, Karin Foeken(Radboud University Nijmegen), Daniëlle C. Cath(University Medical Center Groningen), Rob van den Brink(Leiden University), Wessel Strootker(Rotterdam University of Applied Sciences), Joost Mertens(GGZ inGeest)
Cited by 0
Related Papers
Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis
|The Lancet|2018|3.5k
Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis
|FOCUS The Journal of Lifelong Learning in Psychiatry|2018|342
Structured patient–clinician communication and 1-year outcome in community mental healthcare
|The British Journal of Psychiatry|2007|227
Endogenous Opioid Release in the Human Brain Reward System Induced by Acute Amphetamine Administration
|Biological Psychiatry|2012|145